BioXcel Therapeutics Announces Proposed Public Offering

1 day ago · BioXcel Therapeutics Announces Proposed Public Offering. November 21, 2024 16:47 ET | Source: BioXcel Therapeutics. Follow. NEW HAVEN, Conn., Nov. 21, 2024 …

CouponFollow Extension

$60
OFF

BioXcel Therapeutics Announces Termination Of Proposed Public …

6 days from now

Nov 2, 2023 · --BioXcel Therapeutics, Inc., ... today announced that it has terminated its proposed public offering of $60.0 million of shares of its common stock or, in lieu of common stock to …

nasdaq.com

$60
OFF

BioXcel Therapeutics Terminates $60 Mln Proposed Public Offering

6 days from now

Feb 13, 2024 · (RTTNews) - Tuesday, BioXcel Therapeutics, Inc. (BTAI) announced the termination of its proposed public offering of $60 million in common stock which was …

businessinsider.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

21 hours ago · BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript; BioXcel announces common stock and warrants offering, no amount given; BioXcel Therapeutics …

seekingalpha.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence …

bioxceltherapeutics.com

$60
OFF

BioXcel Therapeutics Announces $60M Proposed Public Offering

6 days from now

Feb 9, 2024 · BioXcel Therapeutics Inc. a New Haven-based biopharmaceutical company, announced a $60 million proposed public offering on Thursday. The firm, which uses artificial …

hartfordbusiness.com

$7
OFF

BioXcel Therapeutics Announces $7M Public Offering

6 days from now

19 hours ago · By David Krechevsky. BioXcel Therapeutics Inc., a New Haven-based biopharmaceutical company that uses artificial intelligence to develop medicines in …

hartfordbusiness.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

BioXcel Therapeutics (NASDAQ:BTAI) on Friday announced the pricing of an underwritten public offering of 5.6M shares of its common stock and accompanying warrants to purchase up to …

msn.com

$0.00
OFF

BioXcel Therapeutics Prices 5.6M Shares At 48c In Public Offering

6 days from now

1 day ago · BioXcel Therapeutics announced the pricing of an underwritten public offering of 5,600,000 shares of its common stock, par value $0.001 per share and accompanying …

businessinsider.com

$30
OFF

Spyre Therapeutics Announces Proposed Public Offering Of Its …

6 days from now

4 days ago · In addition, the Company is expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional $30.0 million of shares of …

prnewswire.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million

6 days from now

21 hours ago · BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering. NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the …

globenewswire.com

FAQs about BioXcel Therapeutics Announces Proposed Public Offering Coupon?

Is bioxcel Therapeutics a biopharmaceutical company?

NEW HAVEN, Conn., Aug. 06, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced its financial results for the second quarter of 2024. ...

What happened to bioxcel Therapeutics shares?

BioXcel Therapeutics shares were up 13% at $2.21 after the company terminated its proposed public offering of $60 million of shares or pre-funded warrants, which it had announced last week. The stock hit its 52-week low of $1.91 on Feb. 9, and is down 93% in the past 12 months. ...

What happened to bioxcel Therapeutics (btai)?

(RTTNews) - Tuesday, BioXcel Therapeutics, Inc. (BTAI) announced the termination of its proposed public offering of $60 million in common stock which was previously announced on February 8, 2024. Following this news stock gained 11%. ...

How did bioxcel Therapeutics perform in the second quarter of 2024?

NetLoss: BioXcel Therapeutics had a net loss of $8.3 million for the second quarter of 2024**, compared to a net loss of $53.5 million for the same period in 2023. The Company used $23.2 million in operating cash during the second quarter of 2024. Cash and cash equivalents totaled $56.3 million as of June 30, 2024. ...

How much did bioxcel Therapeutics raise in an IPO?

BioXcel Therapeutics (BTAI) raised $60 million in their IPO on Thursday, March 8th 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. $60 million was raised in the IPO. ...

Why were bioxcel Therapeutics shares up 12% in premarket trading?

BioXcel Therapeutics shares were up 12% to $3.44 in premarket trading after the company said the U.S. Patent and Trademark Office has allowed a patent application with claims pertaining to a method of treating agitation in patients with Alzheimer's disease. ...